XBiotech (XBIT) Balance Sheet: Assets & Liabilities

XBiotech (XBIT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), XBiotech reported total assets of $150.08M and total liabilities of $9.73M. Shareholders' equity was $140.35M, down 23.0% from $182.27M a year earlier. Total debt stood at $0.00 against $125.55M in cash and short-term investments, a net cash position of $125.55M. That puts debt-to-equity at 0.00, compared with 0.06 a year earlier.

XBiotech Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for XBiotech Inc. (XBIT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	125.55	172.68	200.02	157.31	236.98	237.37	714.59	15.82	31.77
Short-Term Investments	0.00	0.00	0.00	60.17	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	125.55	172.68	200.02	217.48	236.98	237.37	714.59	15.82	31.77
Accounts Receivable	0.36	0.86	0.94	1.76	8.95	10.69	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.04	1.03	0.76	0.60	0.93	0.58	3.34	1.19	1.56
Total Current Assets	126.95	174.57	201.72	219.84	246.87	325.88	716.26	17.02	33.33
Non-Current Assets
Property, Plant & Equipment (Net)	23.13	24.53	24.90	26.26	28.31	27.34	25.17	27.33	29.64
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	75.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	-1.66	-1.09	0.00	75.00	0.00	0.00
Total Non-Current Assets	23.13	24.53	24.90	26.26	28.31	27.87	100.61	27.33	29.64
Total Assets	150.08	199.09	226.62	246.10	275.18	353.74	816.88	44.35	62.97
Current Liabilities
Accounts Payable	1.54	2.22	2.52	2.41	2.07	2.49	2.15	1.65	1.73
Short-Term Debt	0.00	10.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	1.14	2.02	3.50	1.60	0.89	1.35	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	4.50	0.00	0.00
Other Current Liabilities	6.32	0.91	3.50	0.06	1.37	1.35	4.18	1.29	1.06
Total Current Liabilities	7.93	15.11	6.10	4.07	3.45	3.98	60.19	2.94	2.79
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities	0.01	0.00	0.00	0.06	0.87	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	1.80	1.72	1.67	1.64	1.47	1.12	1.06	0.00	0.02
Total Non-Current Liabilities	1.80	1.72	1.67	1.64	2.34	1.12	1.06	0.00	0.02
Total Liabilities	9.73	16.83	7.77	5.70	5.79	5.11	61.25	2.95	2.81
Stockholders' Equity
Common Stock	276.73	273.11	271.15	267.33	262.26	249.81	324.81	279.35	277.49
Retained Earnings	-136.38	-90.84	-52.31	-27.75	5.15	97.57	430.93	-237.70	-216.56
Accumulated Other Comprehensive Income	0.00	0.00	-	0.83	1.97	1.27	-0.11	-0.26	-0.77
Shares Outstanding	30.49	30.49	30.44	30.44	30.44	-	-	-	-
Total Stockholders' Equity	140.35	182.27	218.85	240.40	269.39	348.64	755.63	41.40	60.16
Total Liabilities & Equity	150.08	199.09	226.62	246.10	275.18	353.74	816.88	44.35	62.97

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About XBiotech Balance Sheet

How much debt does XBiotech have?

XBiotech had total debt of $0.00 as of Dec 31, 2025, against $125.55M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $10.25M a year earlier.

What are XBiotech's total assets?

XBiotech reported total assets of $150.08M as of Dec 31, 2025, down 24.6% from $199.09M a year earlier. Total liabilities were $9.73M.

What is XBiotech's shareholders' equity?

XBiotech's shareholders' equity was $140.35M as of Dec 31, 2025, or about $4.60 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition